Syngene Acquires US Biologics Site for mAbs Manufacturing
Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO) announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines. Syngene's investment in its first facility in the United St…
